| |  Online-Ressource |
|---|
| Verfasst von: | Theile, Dirk [VerfasserIn]  |
|---|
| | Ketabi-Kiyanvash, Nahal [VerfasserIn] |
|---|
| | Herold-Mende, Christel [VerfasserIn] |
|---|
| | Dyckhoff, Gerhard [VerfasserIn] |
|---|
| | Efferth, Thomas [VerfasserIn] |
|---|
| | Bertholet, Vincent [VerfasserIn] |
|---|
| | Haefeli, Walter E. [VerfasserIn] |
|---|
| | Weiß, Johanna [VerfasserIn] |
|---|
| Titel: | Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma |
|---|
| Verf.angabe: | Dirk Theile, MSc, Nahal Ketabi-Kiyanvash, PhD, Christel Herold-Mende, PhD, Gerhardt Dyckhoff, MD,Thomas Efferth, PhD, Vincent Bertholet, PhD, Walter Emil Haefeli, MD, Johanna Weiss, PhD |
|---|
| Jahr: | 2011 |
|---|
| Umfang: | 10 S. |
|---|
| Fussnoten: | Erstmals am 24. August 2010 online veröffentlicht ; Gesehen am 27.10.2022 |
|---|
| Titel Quelle: | Enthalten in: Head & neck |
|---|
| Ort Quelle: | New York, NY [u.a.] : Wiley Interscience, 1979 |
|---|
| Jahr Quelle: | 2011 |
|---|
| Band/Heft Quelle: | 33(2011), 7 vom: Juli, Seite 959-968 |
|---|
| ISSN Quelle: | 1097-0347 |
|---|
| Abstract: | Background. Multidrug resistance (MDR) hampers chemotherapy in head and neck squamous cell carcinoma (HNSCC). There is little information about MDR mediating drug transporters in HNSCC. Methods. Nine HNSCC cell lines were characterized concerning drug transporter expression and susceptibility to cisplatin, paclitaxel, and 5-fluorouracil (5-FU) using a DNA microarray and proliferation assays. Three cells lines were precisely investigated for transporter expression using reverse transcriptase-polymerase chain reaction (RT-PCR) and drug resistance before and after simulated chemotherapies. Results. The cell lines differed in drug resistance and transporter expression. Cisplatin and paclitaxel resistances were inversely associated. Drugs rendered HNSCC cells resistant, cross-resistant, or cross-sensitive. Sensitivity changes were accompanied by transporter mRNA expression changes. Conclusion. Paclitaxel was identified as a potent inducer of numerous drug transporters and phenotypic MDR in HNSCC. Thus, cytostatic susceptibility of HNSCC cannot exclusively be deduced from the expression of single transporters but more likely of the entire transportome and non-transporter modulators. © 2010 Wiley Periodicals, Inc. Head Neck, 2011 |
|---|
| DOI: | doi:10.1002/hed.21559 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1002/hed.21559 |
|---|
| | Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.21559 |
|---|
| | DOI: https://doi.org/10.1002/hed.21559 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | cross-resistance |
|---|
| | drug transporters |
|---|
| | head and neck squamous cell carcinoma (HNSCC) |
|---|
| | multidrug resistance |
|---|
| K10plus-PPN: | 1820216012 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma / Theile, Dirk [VerfasserIn]; 2011 (Online-Ressource)
